Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In addition, patients frequently report that the reductions in substance use cravings occur immediately when they increase their dose and sometimes report that cravings return weekly as they reach day 5 or 6 before taking their next injection on day 7
It is given as a weekly injection and has been shown in clinical trials to produce significant weight loss over months of treatment
Copper toxicity from exogenous GHK-Cu at standard doses (1-2 mg/injection) is not documented in the published literature, and the copper is chelated rather than free-ionic, reducing the risk of oxidative toxicity
In vivo data were analysed with a two-way ANOVA followed by Tukeys post-hoc test (fasted glucose levels, ipGTT glucose excursion, body weight and food intake) or a one-way ANOVA followed by Dunnetts or Tukeys post-hoc test (glucose AUC, terminal fat and clinical chemistry data)
&srotate=0)
